2014 annual financial data
Viridian Therapeutics 2014 Operating margin
Direct answer
Operating margin was -158.96%.
Operating income was -6,867,000 USD and net income was -7,890,000 USD.
Operating cash flow was -2,213,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,320,000 USD
- Operating income
- -6,867,000 USD
- Net income
- -7,890,000 USD
- Operating cash flow
- -2,213,000 USD